Literature DB >> 16557942

Role of Biological Mimicry in the Pathogenesis of Rat Arthritis Induced by Mycoplasma arthritidis.

J F Cahill1, B C Cole, B B Wiley, J R Ward.   

Abstract

Complement fixation (CF), immunofluorescence, and agar gel double-diffusion tests were used to demonstrate an antigenic relationship between rat tissues and Mycoplasma arthritidis. Rabbit antisera against six strains of M. arthritidis exhibited positive reactions in the CF test with an ethyl alcohol-saline extract of rat muscle, whereas only 6 of 18 antisera against other Mycoplasma species were positive. With the use of gel diffusion techniques, absorption of various M. arthritidis antigens with antiserum against rat muscle removed at least one precipitin band when the absorbed mycoplasma antigens were reacted against homologous antisera. Rabbit antiserum against M. arthritidis was conjugated with fluorescein isothiocyanate and reacted against frozen sections of muscle tissues of various animals. As controls, unlabeled normal rabbit serum and rabbit anti-M. arthritidis serum were included to determine the specificity of the reaction. Rat, hamster, and mouse skeletal muscle exhibited specific fluorescence, whereas chicken, beef, frog, and turtle muscles exhibited no specific fluorescence. Mice injected at birth with rat lymphocytes were found to be more susceptible to subsequent infection by M. arthritidis than were normal mice or mice injected at birth with mouse lymphocytes. These results indicate the occurrence of a heterogenetic antigen(s) common to M. arthritidis and rat tissues. Preliminary evidence suggests that this heterogenetic antigen(s) may enable the mycoplasmas to become established in their host.

Entities:  

Year:  1971        PMID: 16557942      PMCID: PMC416102          DOI: 10.1128/iai.3.1.24-35.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Induced susceptibility of turkeys to the Rous virus after treatment in the embryonic stage with normal chicken blood.

Authors:  R J HARRIS; M SIMONSEN
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1956

2.  Antigen from colon of germfree rats and antibodies in human ulcerative colitis.

Authors:  P Perlmann; S Hammarström; R Lagercrantz; B E Gustafsson
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

3.  The evaluation of the metabolic-inhibition technique for the study of Mycoplasma gallisepticum.

Authors:  D Taylor-Robinson; D M Berry
Journal:  J Gen Microbiol       Date:  1969-01

4.  Mycoplasmacidal action of normal tissue extracts.

Authors:  E Kaklamanis; L Thomas; K Stavropoulos; I Borman; C Boshwitz
Journal:  Nature       Date:  1969-03-01       Impact factor: 49.962

5.  Tissue cultures and mycoplasmas.

Authors:  L Hayflick
Journal:  Tex Rep Biol Med       Date:  1965-06

6.  Production of anti-Mycoplasma (PPLO) antibodies in rabbits.

Authors:  H E Morton; R J Roberts
Journal:  Proc Soc Exp Biol Med       Date:  1967-06

7.  Serological relationship between galactans from normal bovine lung and from Mycoplasma mycoides.

Authors:  M Shifrine; R N Gourlay
Journal:  Nature       Date:  1965-10-30       Impact factor: 49.962

8.  A comparative study on the virulence of Mycoplasma arthritidis and "Mycoplasma hominis, type 2" strains in rats.

Authors:  B C Cole; M L Miller; J R Ward
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

9.  Immunological responses of the rat to Mycoplasma arthritidis.

Authors:  B C Cole; J F Cahill; B B Wiley; J R Ward
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

10.  An immunological relationship between the group. A streptococcus and mammalian muscle.

Authors:  J B Zabriskie; E H Freimer
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  20 in total

1.  Antigenic mimicry of a human cellular polypeptide by Mycoplasma hyorhinis.

Authors:  P D Fernsten; K W Pekny; J R Harper; L E Walker
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

2.  New models of chronic synovitis in rabbits induced by mycoplasmas: microbiological, histopathological, and immunological observations on rabbits injected with Mycoplasma arthritidis and Mycoplasma pulmonis.

Authors:  B C Cole; M M Griffiths; E J Eichwald; J R Ward
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

3.  Immunogenic cross-reactivity between human tissues and the enterobacterial common antigen.

Authors:  M A Morgenstern; E A Gorzynski
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

4.  Immunologic reactions of rabbit anti-Mycoplasma arthritidis serum with in vitro cultivated rat synovial cells.

Authors:  C E Thirkill; H G Muchmore; R M Hyde; L V Scott
Journal:  In Vitro       Date:  1981-05

5.  Characterization of the metabolism inhibition antigen of Mycoplasma arthritidis.

Authors:  L R Washburn; J R Ramsay; L K Roberts
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

6.  Interaction of Mycoplasma arthritidis and other mycoplasmas with murine peritoneal macrophages.

Authors:  B C Cole; J R Ward
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

7.  Cross-reactive antigens and lectin as determinants of symbiotic specificity in the Rhizobium-clover association.

Authors:  F B Dazzo; D H Hubbell
Journal:  Appl Microbiol       Date:  1975-12

8.  Identification of an isoschizomer of the HhaI DNA methyltransferase in Mycoplasma arthritidis.

Authors:  Wenyi Luo; Anh-Hue T Tu; Zuhua Cao; Huilan Yu; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2008-11-24       Impact factor: 2.742

9.  Effect of corynebacterium parvum in the induction and course of mycoplasma arthritis of mice.

Authors:  E Kaklamani; P Kaklamanis; L Sparos; D Karalis; K Alikouli; I Koumandaki; D Trichopoulos
Journal:  Clin Rheumatol       Date:  1983-06       Impact factor: 2.980

10.  Fate of intravenously injected Mycoplasma arthritidis in rodents and effect of vaccines.

Authors:  B C Cole; J R Ward
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.